• In the media
  • Another antibiotic crisis: fragile supply lea...
Media - published on 01 Jun 2018

Another antibiotic crisis: fragile supply leads to shortages, reports Reuters

Writing for Reuters, Ben Hirschler covers the Foundation’s new white paper on antibiotic shortages: “Shortages of some life-saving antibiotics are putting growing numbers of patients at risk and fuelling the evolution of “superbugs” that do not respond to modern medicines”.

He notes: “Most antibiotics are cheap, off-patent generic medicines, which is good for affordability. But that also means they have very low profit margins – particularly compared to modern drugs for diseases like cancer – offering manufacturers little incentive to invest in new production facilities, looking at the market factors that.” 

The white paper is titled Shortages, stockouts and scarcity: the issues facing the security of antibiotic supply and the role for pharmaceutical companies”


Learn more

View our detailed overview of each company’s performance in the Index, including breakdowns of their product portfolios and R&D pipelines.